Overall rank by patents
#45,711
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 2 technology areas, active 2017–2020. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
The verdict
Caddo holds 5 US patents across 2 technology areas, rank #45,711 of 50,000 tracked assignees.
Caddo Medical Technologies Llc has been granted 5 US utility patents between 2017 and 2020, placing Caddo Medical Technologies Llc at rank #45,711 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.8 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, Caddo Medical Technologies Llc is one of the more focused assignees in the PatentsView dataset. By volume, Caddo sits between Cyndrx Llc (5 patents, rank #45,707) and Cairn5 Llc (5 patents, rank #45,715) - the closest US assignees by grant volume. The composite Innovation Score of 20.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 1 grants, compared with 4 in the 2015–2019 window, a -75% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Caddo Medical Technologies Llc's 15.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Caddo Medical Technologies Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CYNDRX LLC
5 patents
CYSTECH ELECTRONICS CORP.
5 patents
CYTO365 AB
5 patents
CYTOAURORA BIOTECHNOLOGIES, INC.
5 patents
Caddy Products, Inc.
5 patents
Cafe24 Corp.
5 patents
Caillau
5 patents
Cairn5 LLC
5 patents
Caddo Medical Technologies LLC
5 patents
What this shows Caddo holds 5 patents at rank #45,711, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #45,711 in granted patent volume.
Other assignees with the most granted patents in Caddo's primary technology class.
Caddo's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
21 Top 93% higher than 7% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 20.0% |
| 2018 | 1 | 20.0% |
| 2019 | 2 | 40.0% |
| 2020 | 1 | 20.0% |
Top 2 of 2 technology areas
Overall rank by patents
#45,711
Across all tracked assignees
20.7 out of 100
How to use this portfolio
Caddo's 5 grants land it in the top 93% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.